- Global Pharma News & Resources

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico to Showcase CBD Products at Expoweed Winter Cannabis Meeting in Mexico City

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico to Showcase CBD Products at Expoweed Winter Cannabis Meeting in Mexico City

PR Newswire

SAN DIEGO, Dec. 7, 2018

SAN DIEGO, Dec. 7, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico will be exhibiting at the Expoweed Winter Cannabis Meeting 2018 on Dec. 8-9 at Expo Reforma in Mexico City. This will be the first event of its kind where HempMeds® Mexico will be able to purvey their cannabidiol (CBD) hemp oil products onsite.

At the Expoweed Winter Cannabis Meeting, cannabis industry entrepreneurs will be able to secure supplies for their businesses, as well as specialized merchandise. The event will include two days of intense activity via conferences and workshops, dedicating Dec. 8 to the industrial uses of hemp and Dec. 9 to its medicinal uses.

"HempMeds Mexico is fortunate to have the ability to showcase and sell our CBD products that have just recently been approved for import from the U.S. at the Expoweed Winter Cannabis Meeting," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "Since the historic decision to allow the sale of CBD products in Mexico, our company has been at the forefront of the country's growing industry."

HempMeds® Mexico was the first company to receive a COFEPRIS federal government import permit for Real Scientific Hemp Oil-X™ (RSHO-X™), a cannabis product utilized for a medical indication. Not only is HempMeds® Mexico the first publicly traded company to sell their CBD products in the Mexican market, but they also have a storied history of partnering with local non-profit organizations to provide patients with quick access to their medication.

"The Expoweed Winter Cannabis Meeting will provide the perfect platform to educate the Mexican public about the health benefits of CBD," said HempMeds® Mexico President Raul Elizalde. "We believe that the country has moved in the right direction by sanctioning CBD importation and distribution and are thrilled to be a part of this movement."

About HempMeds® Mexico
HempMeds ® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Andrew Hard, Chief Executive Officer
CMW Media
P. 888-829- 0070


View original content:

SOURCE Medical Marijuana, Inc.

Editor Details

Last Updated: 07-Dec-2018